Position in ARGX
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$70,897,400
+$15,153,036 QoQ
Shares Held
76,417
+0.1% QoQ
Ownership
0.123%
of shares outstanding
% of Portfolio
11.75%
of 13F equity value
Holder Rank
#54
of 505 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ARGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Eagle Health Investments LP holds $387,533,407 across 16 Biotechnology names. ARGX ranks #1 (18.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
This page
|
76,417 | $70,897,400 | |
| 2 | INSM |
INSMED Inc
|
384,130 | $40,955,940 | |
| 3 | BMRN |
Biomarin Pharmaceutical Inc
|
624,676 | $35,743,960 | |
| 4 | SRRK |
Scholar Rock Holding Corp
|
555,272 | $30,539,960 | |
| 5 | PTGX |
Protagonist Therapeutics, Inc
|
248,322 | $30,439,310 | |
| 6 | RARE |
Ultragenyx Pharmaceutical Inc.
|
884,121 | $29,520,800 | |
| 7 | ASND |
Ascendis Pharma A/S
|
106,158 | $28,314,461 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
120,346 | $22,538,398 |
All Filings in ARGX
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $70,897,400 | 76,417 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $55,744,364 | 76,336 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $52,752,793 | 62,730 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $57,109,270 | 77,430 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $42,680,964 | 77,430 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $44,383,956 | 74,990 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $46,118,850 | 74,990 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $40,650,579 | 74,990 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $38,226,255 | 88,890 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $33,304,774 | 84,590 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $32,180,573 | 84,590 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $31,660,972 | 64,400 | Shares | Sole | 2023-10-27 | |
| 2023-06-30 | $25,098,612 | 64,400 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $23,994,152 | 64,400 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $22,843,449 | 60,300 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $21,288,915 | 60,300 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $22,846,464 | 60,300 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $22,040,169 | 69,900 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $21,828,043 | 62,332 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $16,196,864 | 53,632 | Shares | Sole | 2021-10-20 | |
| 2021-06-30 | $16,026,558 | 53,232 | Shares | Sole | 2021-07-19 | |
| 2021-03-31 | $11,740,426 | 42,632 | Shares | Sole | 2021-04-23 | |
| 2020-12-31 | $5,760,340 | 19,587 | Shares | Sole | 2021-02-04 | |
| No filing history on record for this holder in this stock. | ||||||